Ten-Year Retrospective Analysis of Continuous Renal Replacement Therapy in Burn Patients: Impact on Survival and Timing of Initiation

19 November 2024 : Clinical Research

Jerzy Strużyna

^1ACDEFG, Piotr Tomaka^2ABCDFG, Agnieszka Surowiecka

^3ABCDEF, Tomasz Korzeniowski

^1CDEFG*, Grzegorz Wilhelm^3ABDEF, Maciej Łączyk

^4BCEF, Ryszard Mądry

^4ABDF, Magdalena Bugaj-Tobiasz^4BDEF, Sergey Antonov^3BDEF, Łukasz Drozd^4BDE, Aldona S. Stachura^4BDE

DOI: 10.12659/AOT.945815

Ann Transplant 2024; 29:e945815

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 2 The RIFLE (Risk, Injury, Failure, Loss and End-stage renal disease) score.

Stage	eGFR and SCr criteria	UO criteria
Risk	An increase in serum creatinine level of 1.5–1.9 times higher than the baseline valueoreGFR decreased >25%	An urine output <0.5 mL/body weight/per hour within 6–12 hours
Injury	An increase in serum creatinine level of 2–2.9 times higher than baseline valueoreGFR decreased >50%	An urine output <0.5 mL/body weight/per hour within >12 hours
Failure	An increase in serum creatinine level of 3 times higher or >4 mg/dL than baselineoreGFR decreased >75%	An urine output <0.3 mL/body weight/per hour within 24 hoursoranuria notice more than 12 hours
Loss	The loss of renal function >4 weeks
End-stage renal disease	The loss of renal function >3 months

Back to the Article